Inhibition of protein arginine methyltransferase 5 attenuates dialysis-related peritoneal fibrosis via suppression of angiogenesis and inflammatory state
Clinical Science · 09.09.2026 · 140 (9) · 1873-1893
DOI: 10.1042/cs20250416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 20.08.2026. Verfasst von Jinqing Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Peritoneal Fibrosis, Protein-Arginine N-Methyltransferases, Peritoneal Dialysis, Neovascularization, Pathologic. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: National Natural Science Foundation of China (NSFC), Shanghai Scientific Committee of China, the Key Discipline Construction Project of Shanghai Pudong New Area Health Commission.
Abstract (Originalsprache)
Dialysis-related peritoneal fibrosis (PF) is a complication of peritoneal dialysis (PD) that leads to ultrafiltration failure and poor technique survival. Currently, no effective therapeutic strategies are available for PF. Protein arginine methyltransferase 5 (PRMT5), a major epigenetic regulator catalyzing symmetric dimethylation of arginine residues, has been implicated in fibrotic disorders. However, its role in PD-related PF remains entirely unexplored. In the present study, we demonstrate aberrant PRMT5 overexpression in peritoneal samples from PD patients with ultrafiltration failure as well as in murine PF models, in which PRMT5 colocalized with activated fibroblasts and α-SMA-positive myofibroblasts. To further elucidate the specific role of PRMT5, we generated fibroblast-specific PRMT5 knockout mice and established two murine PF models that recapitulate the clinical phenotype. Genetic PRMT5 inhibition attenuated histopathological damage, extracellular matrix deposition, angiogenesis, and inflammatory infiltration induced by high-glucose PD fluid or chlorhexidine gluconate, thereby improving peritoneal transport function. In vitro, we found genetic PRMT5 inhibition mitigated high-glucose-induced mesothelial-to-mesenchymal transition and inflammatory cytokine secretion. Furthermore, pharmacological inhibition of PRMT5 using selective PRMT5 inhibitor EPZ015666 also exhibited therapeutic efficacy in vivo. Mechanistically, our data implicate a PRMT5-mediated inflammation-angiogenesis axis in PF progression. Collectively, our findings establish PRMT5 as a pivotal, druggable epigenetic regulator in dialysis-related PF and provide a compelling rationale for clinical development of PRMT5-targeted strategies to prevent PF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, RI, U.S.A.
ORCID-Profile: Jinqing Li, Na Liu
Förderung
- National Natural Science Foundation of China (NSFC)
- Shanghai Scientific Committee of China
- the Key Discipline Construction Project of Shanghai Pudong New Area Health Commission
- the New Quality Clinical Specialty Program of High-end Medical Disciplinary Construction in Shanghai Pudong New Area
- the Outstanding Leaders Training Program of Pudong Health Bureau of Shanghai
- the Young Medical Talents Training Program of Shanghai Pudong New Area Health Commission
- The grant of Shanghai East Hospital
Zitieren
APA
Li, J., Shi, Y., Chen, H., Jiang, D., Ma, X., Li, X., Wang, P., Zhu, J., Mo, Q., Zhuang, S., & Liu, N. (2026). Inhibition of protein arginine methyltransferase 5 attenuates dialysis-related peritoneal fibrosis via suppression of angiogenesis and inflammatory state. Clinical Science, 140(9), 1873-1893. https://doi.org/10.1042/cs20250416
Vancouver
Li J, Shi Y, Chen H, Jiang D, Ma X, Li X, et al. Inhibition of protein arginine methyltransferase 5 attenuates dialysis-related peritoneal fibrosis via suppression of angiogenesis and inflammatory state. Clinical Science. 2026;140(9):1873-1893. doi:10.1042/cs20250416
BibTeX
@article{Li2026,
author = {Li, Jinqing and Shi, Yingfeng and Chen, Hui and Jiang, Daofang and Ma, Xiaoyan and Li, Xialin and Wang, Peixin and Zhu, Jiayu and Mo, Qingyi and Zhuang, Shougang and Liu, Na},
title = {Inhibition of protein arginine methyltransferase 5 attenuates dialysis-related peritoneal fibrosis via suppression of angiogenesis and inflammatory state},
journal = {Clinical Science},
year = {2026},
volume = {140},
number = {9},
pages = {1873--1893},
doi = {10.1042/cs20250416}
}
EUVIMED